QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-bionano-genomics-bngo-stock-is-getting-hammered-tuesday

BioNano Genomics shares are trading sharply lower in Tuesday's session. The company announced the pricing of a $10 million ...

 bionano-genomics-prices-10m-public-offering-of-5m-shares-and-series-warrants-at-a-combined-price-of-200-could-potentially-earn-20m-from-warrant-exercises

Bionano Genomics, Inc. (NASDAQ:BNGO) ("Bionano" or the "Company") today announced the pricing of a public offer...

 bionano-genomics-selected-for-sole-source-contract-by-nih-for-optical-genome-mapping-reagents-and-instruments-no-contract-value-disclosed

https://sam.gov/opp/7a19a6e8954c4de1a128b841e2018400/view DescriptionThis is a notice of intent, not a request for a quotation....

 hc-wainwright--co-maintains-buy-on-bionano-genomics-raises-price-target-to-11

HC Wainwright & Co. analyst Yi Chen maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and raises the price target from...

 bionano-genomics-q2-eps-199-beats-242-estimate-sales-6733m-miss-6832m-estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2....

 bionano-genomics-affirms-fy2025-sales-guidance-of-26000m-30000m-vs-29363m-est

Bionano Genomics (NASDAQ:BNGO) affirms FY2025 sales outlook from $26.000 million-$30.000 million to $26.000 million-$30.000 mil...

 bionano-genomics-sees-q3-sales-6700m-7200m-vs-7661m-est

Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $6.700 million-$7.200 million vs $7.661 million analyst estimate.

 bionano-genomics-announces-peer-reviewed-study-showing-that-optical-genome-mapping-can-effectively-detect-oncogenic-structural-variants-in-infant-and-toddler-t-cell-acute-lymphoblastic-leukemia

Bionano Genomics, Inc. (NASDAQ:BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Inst...

 maxim-group-upgrades-bionano-genomics-to-buy-announces-8-price-target

Maxim Group analyst Jason McCarthy upgrades Bionano Genomics (NASDAQ:BNGO) from Hold to Buy and announces $8 price target.

 bionano-genomics-lowers-fy2025-sales-guidance-from-2900m-3200m-to-2600m-3000m-vs-3343m-est

Bionano Genomics (NASDAQ:BNGO) lowers FY2025 sales outlook from $29.00 million-$32.00 million to $26.00 million-$30.00 million ...

 bionano-genomics-sees-q2-sales-6300m-6800m-vs-702m-est

Bionano Genomics (NASDAQ:BNGO) sees Q2 sales of $6.300 million-$6.800 million vs $7.02 million analyst estimate.

 bionano-genomics-q1-eps-115-beats-302-estimate-sales-650m-beat-623m-estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.15) per share which beat the analyst consensus estimate of $(3....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION